搜尋結果
文章
Kuo, C. N. ,
Pan, J. J. ,
Huang, Y. W. ,
Tsai, H. J. &
Chang, W. C. ,
7月 1 2018 ,
於: Cancer Epidemiology Biomarkers and Prevention. 27 ,
7 ,
p. 737-745 9 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Case-Control Studies
100%
Colorectal Neoplasms
98%
Anti-Inflammatory Agents
91%
Pharmaceutical Preparations
51%
Population
48%
Hung, S-H. ,
Wang, L-H. ,
Lin, H-C. &
Chung, S. D. ,
9月 2014 ,
於: Drug Safety. 37 ,
9 ,
p. 735-742 8 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
100%
Bell Palsy
97%
Hydroxymethylglutaryl-CoA Reductase Inhibitors
67%
Population
27%
Health Insurance
18%
Lei, Y. F. ,
Lin, H. C. ,
Lin, H. L. ,
Uang, Y. S. ,
Cheng, H. W. &
Wang, L. H. ,
2020 ,
於: International Journal of COPD. 15 ,
p. 2573-2581 9 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Hypolipidemic Agents
100%
Fibric Acids
77%
Hyperlipidemias
74%
Chronic Obstructive Pulmonary Disease
66%
Hydroxymethylglutaryl-CoA Reductase Inhibitors
56%
Kuo, H. C. ,
Chang, W-C. ,
Wang, L. J. ,
Li, S. C. &
Chang, W. P. ,
12月 1 2016 ,
於: Epidemiology and Psychiatric Sciences. 25 ,
6 ,
p. 573-580 8 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Mucocutaneous Lymph Node Syndrome
100%
ADHD
83%
Attention Deficit Disorder with Hyperactivity
79%
Cohort Studies
53%
Population
30%
Kao, C. C. ,
Cheng, S. Y. ,
Wang, Y. J. ,
Chien, S. C. ,
Hsu, Y. W. ,
Wu, M. Y. ,
Lu, H. F. ,
Nam, S. ,
Sun, T. ,
Wu, M. S. &
Chang, W. C. ,
6月 5 2019 ,
於: BMC Nephrology. 20 ,
1 ,
p. 203 203.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Endothelins
100%
Chronic Kidney Failure
75%
Bacteremia
52%
Infections
41%
Single Nucleotide Polymorphism
28%
Chen, Y. C. ,
Wu, M. Y. ,
Yu, Z. L. ,
Chou, W. H. ,
Lai, Y. T. ,
Kao, C. C. ,
Faridah, I. N. ,
Wu, M. S. &
Chang, W. C. ,
11月 6 2020 ,
於: Journal of Personalized Medicine. 10 ,
4 ,
p. 1-12 12 p. , 210.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Ubiquitin-Protein Ligases
100%
Diabetic Nephropathies
93%
Haplotypes
49%
Kidney
46%
Chronic Kidney Failure
46%
Kao, C. C. ,
Cheng, S. Y. ,
Wu, M. Y. ,
Chien, S. C. ,
Lu, H. F. ,
Hsu, Y. W. ,
Zhang, Y. F. ,
Wu, M. S. &
Chang, W. C. ,
9月 7 2017 ,
於: BMC Nephrology. 18 ,
1 , 291.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Endothelins
100%
Renal Insufficiency
75%
Chronic Kidney Failure
60%
Genes
27%
Tibial Arteries
24%
Lu, H. F. ,
Hung, K. S. ,
Hsu, Y. W. ,
Tai, Y-T. ,
Huang, L. S. ,
Wang, Y. J. ,
Wong, H. S. C. ,
Hsu, Y. H. &
Chang, W. C. ,
10月 22 2015 ,
於: PLoS One. 10 ,
10 , e0140549.
研究成果: 雜誌貢獻 › 文章 › 同行評審
osteoporosis
100%
Osteoporosis
65%
genetic polymorphism
15%
bone density
14%
Population
12%
Wei, J. C. C. ,
Hsu, Y. W. ,
Hung, K. S. ,
Wong, R. H. ,
Huang, C. H. ,
Liu, Y. T. ,
Guo, Y. C. ,
Ikegawa, S. &
Chang, W. C. ,
1月 4 2013 ,
於: PLoS ONE. 8 ,
1 , e52801.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Ankylosing Spondylitis
100%
Population
34%
Genetic Polymorphisms
23%
Inflammatory Bowel Diseases
20%
Spondylitis
15%
Liao, J. H. ,
Chen, C. S. ,
Maher, T. J. ,
Liu, C. Y. ,
Lin, M. H. ,
Wu, T. H. &
Wu, S. H. ,
3月 16 2009 ,
於: Chemical Research in Toxicology. 22 ,
3 ,
p. 518-525 8 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
astaxanthine
100%
Selenious Acid
95%
Astaxanthin
94%
Selenites
82%
Selenic Acid
12%
Wu, T. H. ,
Liao, J. H. ,
Hou, W. C. ,
Huang, F. Y. ,
Maher, T. J. &
Hu, C. C. ,
3月 22 2006 ,
於: Journal of Agricultural and Food Chemistry. 54 ,
6 ,
p. 2418-2423 6 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
astaxanthine
100%
Astaxanthin
94%
Crystallins
84%
astaxanthin
78%
protein degradation
68%
Lim, L. M. ,
Chang, J. M. ,
Wang, I. F. ,
Chang, W. C. ,
Hwang, D. Y. &
Chen, H. C. ,
9月 27 2013 ,
於: BMC Pediatrics. 13 ,
1 , 150.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Bruton type agammaglobulinemia
100%
Agammaglobulinaemia Tyrosine Kinase
96%
Immunoglobulin M
58%
Mutation
37%
Proteinuria
27%
Liao, J. H. ,
Lin, Y. C. ,
Hsu, J. ,
Lee, A. Y. L. ,
Chen, T. A. ,
Hsu, C. H. ,
Chir, J. L. ,
Hua, K. F. ,
Wu, T. H. ,
Hong, L. J. ,
Yen, P. W. ,
Chiou, A. &
Wu, S. H. ,
3月 3 2010 ,
於: Biophysical Journal. 98 ,
5 ,
p. 932 1 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
E coli Lon protein
100%
Taiwan
45%
Escherichia coli
32%
Publications
19%
Liao, J. H. ,
Lin, Y. C. ,
Hsu, J. ,
Lee, A. Y. L. ,
Chen, T. A. ,
Hsu, C. H. ,
Chir, J. L. ,
Hua, K. F. ,
Wu, T. H. ,
Hong, L. J. ,
Yen, P. W. ,
Chiou, A. &
Wu, S. H. ,
1月 6 2010 ,
於: Biophysical Journal. 98 ,
1 ,
p. 129-137 9 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
E coli Lon protein
100%
Protease La
37%
Escherichia coli
32%
Adenosine Triphosphate
17%
Proteins
17%
Klahan, S. ,
Huang, C. C. ,
Chien, S-C. ,
Wu, M. S. ,
Wong, H. S. C. ,
Huang, C. Y. ,
Chang, W. C. &
Wei, P. L. ,
1月 1 2016 ,
於: Tumor Biology. 37 ,
1 ,
p. 583-590 研究成果: 雜誌貢獻 › 文章 › 同行評審
Oxaliplatin
100%
Computational Biology
79%
Colonic Neoplasms
63%
phosphatidylinositol 4,5-biphosphate kinase
23%
Toll-Like Receptor 5
22%
Cho, E. C. ,
Chang-Jian, C. W. ,
Lu, C. Z. ,
Huang, J. H. ,
Hsieh, T. H. ,
Wu, N. J. ,
Lee, K. C. ,
Hsu, S. C. &
Weng, H. C. ,
2月 1 2022 ,
於: Polymers. 14 ,
3 , 575.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Porous carbon
100%
Phenolic resins
86%
Lithium
70%
Capacitor
65%
Ions
58%
Hsu, F-L. ,
Yang, L. M. ,
Chang, S. F. ,
Wang, L. H. ,
Hsu, C-Y. ,
Liu, P. C. &
Lin, S. J. ,
3月 2007 ,
於: Applied Microbiology and Biotechnology. 74 ,
3 ,
p. 659-666 8 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Beauveria
100%
Biotransformation
95%
Gallic Acid
74%
Acids
50%
Pyrans
45%
Wang, L. H. ,
Hsu, K. Y. ,
Uang, Y. S. ,
Hsu, F-L. ,
Yang, L. M. &
Lin, S. J. ,
6月 2010 ,
於: Phytotherapy Research. 24 ,
6 ,
p. 852-858 7 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
caffeic acid
100%
Levodopa
77%
3-methoxytyrosine
68%
Biological Availability
62%
Rabbits
49%
Kao, C. C. ,
Liu, J. S. ,
Chang, Y. K. ,
Lin, M. H. ,
Lin, Y. C. ,
Chen, H. H. ,
Chang, W. C. ,
Hsu, C. C. &
Wu, M. S. ,
1月 1 2018 ,
於: PeerJ. 2018 ,
11 , e5864.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Mammalian Target of Rapamycin Inhibitor
100%
kidney transplant
85%
Kidney Transplantation
54%
Antineoplastic Agent
51%
neoplasms
44%
Fang, J. Y. ,
Fang, C. L. ,
Hong, C. T. ,
Chen, H. Y. ,
Lin, T. Y. &
Wei, H. M. ,
2000 ,
於: European Journal of Pharmaceutical Sciences. 12 ,
3 ,
p. 195-203 9 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
nonivamide
100%
Nonivamide
99%
Penetration Enhancing Agent
74%
Capsaicin
71%
Indomethacin
50%
Yang, K. C. ,
Zheng, J. H. ,
Chen, Y. L. ,
Lee, K. C. &
Cho, E. C. ,
2016 ,
於: RSC Advances. 6 ,
58 ,
p. 53025-53033 9 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Reactive oxygen species
100%
Scavenging
76%
Titanium dioxide
73%
Nanostructured materials
69%
Solubility
61%
Liao, J. H. ,
Lin, I. L. ,
Huang, K. F. ,
Kuo, P. T. ,
Wu, S. H. &
Wu, T. H. ,
6月 25 2014 ,
於: Journal of Agricultural and Food Chemistry. 62 ,
25 ,
p. 5932-5938 7 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Carnosine
100%
carnosine
97%
Crystallins
87%
calpain
87%
Turbidity
73%
Wong, H. S. C. ,
Chang, C. M. ,
Liu, X. ,
Huang, W. C. &
Chang, W. C. ,
11月 1 2016 ,
於: OncoImmunology. 5 ,
11 , e1214789.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Cytokines
100%
Neoplasms
81%
Chemokines
21%
Datasets
18%
Down-Regulation
16%
Chang, C. M. ,
Hsu, Y. W. ,
Wong, H. S. C. ,
Wei, J. C. C. ,
Liu, X. ,
Liao, H. T. &
Chang, W. C. ,
1月 1 2019 ,
於: Disease Markers. 2019 ,
1 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Antirheumatic Agent
100%
Biological Therapy
75%
T-Cell Antigen Receptor
64%
Rheumatoid Arthritis
52%
Antirheumatic Agents
45%
Chou, C. K. ,
Li, Y. C. ,
Chen, S. M. ,
Shih, Y. M. &
Lee, J. A. ,
2015 ,
於: BioMed Research International. 2015 , 675714.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Chitosan
100%
Gentamicins
94%
Molecular Weight
75%
Aminoglycosides
66%
Aminoglycoside
60%
Yen, Y. H. ,
Chen, H. Y. ,
Leu, W. J. ,
Lin, Y. M. ,
Shen, W. C. &
Cheng, K. J. ,
2月 2012 ,
於: International Journal of Clinical Pharmacology and Therapeutics. 50 ,
2 ,
p. 136-141 6 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Levofloxacin
100%
Taiwan
81%
Economics
63%
Length of Stay
62%
Pharmacists
54%
Wu, M. T. M. ,
Chen, H. Y. ,
Ou, T. Y. ,
Kuo, L. N. ,
Cheng, K. J. &
Lee, W. S. ,
12月 1 2014 ,
於: International Journal of Clinical Pharmacology and Therapeutics. 52 ,
12 ,
p. 1030-1036 7 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Tigecycline
100%
Cross Infection
73%
Taiwan
72%
Acinetobacter baumannii
32%
Acinetobacter Infections
30%
Kao, C. C. ,
Wang, S. Y. ,
Chuang, Y. K. ,
Lee, W. Y. ,
Chang, W. C. ,
Wu, M. S. ,
Kuo, T. C. &
Tsai, I. L. ,
8月 2021 ,
於: Journal of Personalized Medicine. 11 ,
8 , 761.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Mass Spectrometry
100%
Immunoglobulin G
83%
Kidney
59%
Glycopeptides
35%
Glomerular Filtration Rate
26%
Chang, W-C. ,
Yang, K. D. ,
Wu, M-T. M. ,
Wen, Y-F. ,
Hsi, E. ,
Chang, J-C. ,
Lin, Y-M. ,
Kuo, H-C. &
Chang, W. P. ,
11月 20 2013 ,
於: PLoS One. 8 ,
11 , e80285.
研究成果: 雜誌貢獻 › 文章 › 同行評審
immunoglobulin E
100%
Immunoglobulin E
63%
Asthma
53%
allergic rhinitis
51%
Taiwan
51%
Cho, E-C. ,
Chang-Jian, C-W. ,
Huang, J-H. ,
Lee, G-Y. ,
Hung, W-H. ,
Sung, M-Y. ,
Lee, K-C. ,
Weng, H. C. ,
Syu, W-L. ,
Hsiao, Y-S. &
Chen, C-P. ,
1月 15 2021 ,
於: Journal of Hazardous Materials. 402 ,
p. 123457 123457.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Rhodamine B
100%
Photodegradation
91%
rhodamine B
91%
Antibiotics
81%
Photolysis
81%
Chang, S. C. ,
Lu, M. L. ,
Wang, Y. C. ,
Lin, F. W. ,
Huang, S. H. ,
Kuo, P. H. ,
Ho, H. O. &
Wu, T. H. ,
6月 2012 ,
於: Therapeutic Drug Monitoring. 34 ,
3 ,
p. 345-348 4 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Thioridazine
100%
Quetiapine Fumarate
89%
Therapeutics
11%
Schizophrenia
10%
Pharmacokinetics
9%
Chang, T. Y. ,
Chien, J. Y. ,
Wu, C. H. ,
Dong, Y. H. &
Lin, F. J. ,
5月 2020 ,
於: Chest. 157 ,
5 ,
p. 1117-1129 13 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Formoterol Fumarate
100%
Chronic Obstructive Pulmonary Disease
63%
Beclomethasone
61%
Adrenal Cortex Hormones
57%
Budesonide
45%
Liu, J. W. ,
Lin, S. H. ,
Wang, L. C. ,
Chiu, H. Y. &
Lee, J. A. ,
8月 2 2021 ,
於: JAMA network open. 4 ,
8 , e2119151.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Network Meta-Analysis
100%
Human Influenza
68%
Antiviral Agents
63%
Systematic Reviews
54%
Child
32%
Lin, L. Y. ,
Yang, T. H. ,
Lin, Y. J. ,
Yu, H. R. ,
Yang, K. D. ,
Huang, Y. C. ,
Chang, W. C. &
Kuo, H. C. ,
12月 2012 ,
於: Pediatric Cardiology. 33 ,
8 ,
p. 1269-1274 6 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Mucocutaneous Lymph Node Syndrome
100%
Enterovirus
90%
Intravenous Immunoglobulins
87%
Eosinophils
32%
Passive Immunization
27%
Lai, N. H. ,
Shen, W. C. ,
Lee, C. N. ,
Chang, J. C. ,
Hsu, M. C. ,
Kuo, L. N. ,
Yu, M. C. &
Chen, H. Y. ,
5月 2020 ,
於: Computer Methods and Programs in Biomedicine. 188 , 105307.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Machine Learning
100%
Tuberculosis
72%
Support Vector Machine
72%
Forests
70%
Machine learning
64%
Lee, T. Y. ,
Chen, C. M. ,
Lee, C. N. ,
Chiang, Y. C. &
Chen, H. Y. ,
4月 15 2005 ,
於: American Journal of Health-System Pharmacy. 62 ,
8 ,
p. 828-833 6 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Ipratropium
100%
ipratropium drug combination fenoterol
92%
Fenoterol
86%
Osmolality
74%
Acetylcysteine
57%
Klahan, S. ,
Wu, M. S. ,
Hsi, E. ,
Huang, C. C. ,
Hou, M. F. &
Chang, W. C. ,
2014 ,
於: BioMed Research International. 2014 , 536591.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Triple Negative Breast Neoplasms
100%
Cell Movement
67%
Messenger RNA
47%
Microarrays
44%
Estrogen
44%
Lin, H. W. ,
Chang, E. H. ,
Ko, Y. ,
Wang, C. Y. ,
Wang, Y. S. ,
Mafruhah, O. R. ,
Wu, S. H. ,
Chen, Y. C. &
Huang, Y. M. ,
10月 1 2020 ,
於: International journal of environmental research and public health. 17 ,
19 ,
p. 1-17 17 p. , 6951.
研究成果: 雜誌貢獻 › 文章 › 同行評審
literacy
100%
Health Literacy
93%
Literacy
89%
Psychometrics
70%
Label
66%
Liao, W. H. ,
Lin, C. R. ,
Wei, D. H. ,
Shen, Y. R. ,
Li, Y. C. ,
Lee, J. A. &
Liang, C. Y. ,
11月 2012 ,
於: Journal of Biomedical Materials Research - Part A. 100 A ,
11 ,
p. 3151-3156 6 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Diamond like carbon films
100%
Biocompatibility
78%
Doping (additives)
71%
Nitrogen
59%
Liquid Film
30%
Wu, C. S. ,
Chen, Y. H. ,
Chen, C. L. ,
Chien, S. K. ,
Syifa, N. ,
Hung, Y. C. ,
Cheng, K. J. ,
Hu, S. C. ,
Lo, P. T. ,
Lin, S. Y. &
Wu, T. H. ,
11月 27 2019 ,
於: BMC Complementary and Alternative Medicine. 19 ,
1 , 335.
研究成果: 雜誌貢獻 › 文章 › 同行評審
dong quai
100%
Herb-Drug Interactions
81%
Ginkgo biloba
76%
Panax
68%
Medicine
39%
3-Hydroxybutyric Acid
100%
High Pressure Liquid Chromatography
63%
Fluorescence
62%
High-Pressure Liquid Chromatography
58%
Voltage
55%
Stromal Interaction Molecule 1
100%
Genetic Profile
80%
Colorectal Neoplasms
49%
Chronic Obstructive Pulmonary Disease
41%
Cell Movement
18%
Huang, Y. H. ,
Yang, K. D. ,
Hsu, Y. W. ,
Lu, H. F. ,
Wong, H. S. C. ,
Yu, H. R. ,
Kuo, H. C. ,
Huang, F. C. ,
Lo, M. H. ,
Hsieh, K. S. ,
Chen, S. F. ,
Chang, W. C. &
Kuo, H. C. ,
2月 7 2017 ,
於: Oncotarget. 8 ,
31 ,
p. 51859-51868 10 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Mucocutaneous Lymph Node Syndrome
100%
Hepcidins
83%
Length of Stay
59%
Intravenous Immunoglobulins
52%
Gene Expression
47%
Siaw, M. Y. L. ,
Malone, D. C. ,
Ko, Y. &
Lee, J. Y. C. ,
12月 2018 ,
於: Journal of Clinical Pharmacy and Therapeutics. 43 ,
6 ,
p. 775-783 9 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Singapore
100%
Risk Management
94%
Cost-Benefit Analysis
74%
Randomized Controlled Trials
58%
Costs and Cost Analysis
46%
Osteoporotic Fractures
100%
Singapore
97%
Indirect Costs
61%
Outpatient
56%
Costs and Cost Analysis
52%
Diabetes Complications
100%
Diabetes Mellitus
78%
Length of Stay
75%
Hospitalization
73%
Costs and Cost Analysis
61%
Chien, C. L. ,
Chen, Y. C. ,
Malone, D. C. ,
Peng, Y. L. &
Ko, Y. ,
9月 2020 ,
於: Current Medical Research and Opinion. 36 ,
10 ,
p. 1619-1626 8 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Metformin
100%
Sodium-Glucose Transport Proteins
94%
Cost-Benefit Analysis
80%
Type 2 Diabetes Mellitus
69%
Quality-Adjusted Life Years
58%
Lin, C. H. ,
Cheng, D. H-W. ,
Hsu, M-J. ,
Chen, M-C. ,
Lin, C. C. &
Chen, B-C. ,
9月 1 2006 ,
於: Journal of Immunology. 177 ,
5 ,
p. 3427-3438 12 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Thrombin
100%
Interleukin-8
96%
Epithelial Cells
72%
Lung
54%
Ro 32-0432
37%
Chang, L. S. ,
Hsu, Y. W. ,
Lu, C. C. ,
Lo, M. H. ,
Hsieh, K. S. ,
Li, S. C. ,
Chang, W. C. &
Kuo, H. C. ,
11月 1 2017 ,
於: Pediatric Infectious Disease Journal. 36 ,
11 ,
p. 1039-1043 5 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Cytochrome P-450 CYP2E1
100%
Mucocutaneous Lymph Node Syndrome
98%
Coronary Vessels
63%
Single Nucleotide Polymorphism
32%
Genes
31%
Long, Z. ,
Lee, J. A. ,
Okamoto, T. ,
Nimura, N. ,
Imai, K. &
Homma, H. ,
10月 5 2000 ,
於: Biochemical and Biophysical Research Communications. 276 ,
3 ,
p. 1143-1147 5 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Prolactin
100%
D-Aspartic Acid
98%
Pituitary Neoplasms
75%
Strain
48%
Anterior Pituitary Gland
44%